Anika Therapeutics (ANIK) Inventory Average: 2011-2025
Historic Inventory Average for Anika Therapeutics (ANIK) over the last 14 years, with Sep 2025 value amounting to $16.6 million.
- Anika Therapeutics' Inventory Average fell 63.55% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.6 million, marking a year-over-year decrease of 63.55%. This contributed to the annual value of $24.1 million for FY2024, which is 24.86% down from last year.
- Per Anika Therapeutics' latest filing, its Inventory Average stood at $16.6 million for Q3 2025, which was down 13.21% from $19.1 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Inventory Average ranged from a high of $50.4 million in Q2 2024 and a low of $16.6 million during Q3 2025.
- For the 3-year period, Anika Therapeutics' Inventory Average averaged around $34.8 million, with its median value being $36.9 million (2024).
- Per our database at Business Quant, Anika Therapeutics' Inventory Average spiked by 37.42% in 2021 and then plummeted by 63.55% in 2025.
- Over the past 5 years, Anika Therapeutics' Inventory Average (Quarterly) stood at $35.5 million in 2021, then increased by 8.41% to $38.5 million in 2022, then fell by 11.49% to $34.1 million in 2023, then decreased by 6.92% to $31.7 million in 2024, then slumped by 63.55% to $16.6 million in 2025.
- Its Inventory Average was $16.6 million in Q3 2025, compared to $19.1 million in Q2 2025 and $22.6 million in Q1 2025.